Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
β-thalassemiaIneffective ErythropoiesisChronic Anemia
Interventions
DRUG

PTG-300

Subcutaneous (SC)

Trial Locations (33)

1006

Bone Marrow Transplant Center, Tunis

1008

Aziza Othmana Hospital, Tunis

1089

Principal Military Hospital, Tunis

4000

University Hospital Farhat Hached, Sousse

10330

Chulalongkorn University, Bangkok

10700

Siriraj Hospital Mahidol University, Bangkok

10990

Hospital Pulau Pinang, George Town

11562

Laiko General Hospital of Athens, Athens

19104

Hospital of The University of Pennsylvania, Philadelphia

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

33343

Mersin University Medical Facult, Mersin

34093

Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul

35100

Ege Universitesi Tip Fakultesi, Izmir

40002

Khon Kaen University, Khon Kaen

50200

Maharaj Nakorn Chiang Mai Chiang Mai University, Chiang Mai

65000

Naresuan University, Phitsanulok

68000

Hospital Ampang, Ampang

72100

Presidio Ospedaliero Antonio Perrino, Brindisi

80100

Hospital Sultanah Aminah, Johor Bahru

80138

AOU dell'Università degli Studi della Campania Luigi Vanvitelli, Napoli

88586

Queen Elizabeth Hospital, Kota Kinabalu

93586

Hospital Umum Sarawak, Kuching

94609

UCSF Benioff Children's Hospital, Oakland

02115

Boston Children's Hospital, Boston

Unknown

University General Hospital of Patras, Pátrai

Athens General Hospital 'G Gennimatas', Athens

Hippokration Hospital, Thessaloniki

Chronic Care Center, Beirut

Barts Health NHS Trust, London

01130

Acibadem Adana Hospital, Adana

06100

Hacettepe University Medical Faculty, Ankara

07059

Akdeniz Universitesi Hastanesi, Antalya

E1 1BB

Barts Health NHS Trust, London

All Listed Sponsors
lead

Protagonist Therapeutics, Inc.

INDUSTRY

NCT03802201 - Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia | Biotech Hunter | Biotech Hunter